<DOC>
	<DOCNO>NCT00092885</DOCNO>
	<brief_summary>The purpose study determine effect approve medication symptom seasonal allergic rhinitis ( seasonal variety inflammation mucous membrane nose ) patient experience symptom seasonal allergic rhinitis asthma .</brief_summary>
	<brief_title>An Approved Drug Study New Indication Seasonal Allergic Rhinitis Patients With Asthma ( 0476-269 )</brief_title>
	<detailed_description>The duration treatment 2 week .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Nonsmoker A 2year documented history seasonal allergic rhinitis A 1year documented history chronic asthma Positive allergy test Medical history lung disorder ( asthma ) recent upper respiratory tract infection .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>